MYBL2 and colonic neoplasm: Besides, in HCT-116 colon cancer cells, ginkgetin-mediated microRNA modulation targeted the miRNA34a/b-Myb/cyclin B1 cascade, resulting in G2 phase arrest through downstream regulation of b-Myb, CDC2, and cyclin B [47].